MET and myeloproliferative neoplasm: Both MET variants were present, jointly in most cases, in the cohorts tested (96 solid tumours, 191 AML, 96 CLL, 32 CMML; no CML and no MPN) but at very low frequencies (<2%) similar to those observed in healthy donors [127].